A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants

Clinical Transplantation

Volumn 14, Issue 4 I, 2000, Pages 340-344

  Hesse, U J ^a   Troisi, R ^a   Jacobs, B ^a   Van Vlem, B ^a   de Hemptinne, B ^a   Van Holder, R ^a   Vermassen, F ^a   De Roose, J ^a   Lameire, N ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ATG; Basiliximab; Cycloporine; Mycophenolate mofetil; Rejection; Simultaneous pancreas kidney transplant

Indexed keywords

AMYLASE; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; LEUKOCYTE ANTIGEN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ISCHEMIA; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVER TOXICITY; MALE; NEPHROTOXICITY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME; UREMIA;

ADULT; ANTIBIOTICS, ANTIFUNGAL; ANTIBODIES, MONOCLONAL; CYCLOSPORINE; FATTY ACIDS, MONOUNSATURATED; FEMALE; GLOBULINS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; THYMUS GLAND;

EID: 0033915994     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140410.x     Document Type: Article

References (18)

1. Annual report of the US scientific registry of transplant recipients and the organ procurement and transplant network
2. Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs. combined kidney and pancreas transplantation
3. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage
4. Analysis of United States (US) and non-US pancreas transplant registry (IPTR) and to the United Network for organ sharing (UNOS)
5. Tacrolimus in pancreas transplantation: A multicenter analysis
6. The US multi-center FK 506 liver study group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation
7. Immunosuppressive effect of mycophenolic acid
8. Mycophenolate mofetil, a rationally designed immunosuppressive drug
9. Mycophenolate mofetil (RS-61443)
10. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation
11. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine
12. European mycophenolate mofetil cooperative study group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
13. Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients
14. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation
15. Review of immunosuppressive usage in pancreas transplantation
16. Arterial reconstruction in hepatic and pancreatic allograft transplantation following multi-organ procurement
17. Effect of preservation solution on results of cadaveric kidney transplantation
18. A review of interleukin-2 receptor antagonists in solid organ transplantation